ArticleCancers2024

Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study.

Matheus Sewastjanow-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.